Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus.
about
Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates, predictors and associations with patient-reported and clinical outcomesPatient-reported adherence to coprescribed proton pump inhibitor gastroprotection in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis patients using nonsteroidal anti-inflammatory drugs.Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters.Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study.A Study Evaluating Adherence and Compliance of Anti-rheumatic Drugs in Women Suffering from Rheumatoid ArthritisNovel Adherence Measures for Infusible Therapeutic Agents Indicated for Rheumatoid ArthritisNanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice.Improving treatment adherence in patients with rheumatoid arthritis: what are the options?Medication adherence in patients in treatment for rheumatoid arthritis and systemic lupus erythematosus in a university hospital in BrazilUse of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs.Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherenceImproving treatment adherence in patients with rheumatologic disease.Etanercept-Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis.Treatment of lupus: impact on quality of life.Economics of non-adherence to biologic therapies in rheumatoid arthritis.What are the effects of medication adherence interventions in rheumatic diseases: a systematic review.Lupus nephritis flare in young patients: relapse or nonadherence to treatment?A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases.Use of pharmacy records to measure treatment adherence: a critical review of the literature.Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important change.Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring.Treatment Satisfaction in Systemic Lupus Erythematosus: Development of a Patient-Reported Outcome Measure.Compliance and persistence with hydroxychloroquine in South Korean patients with systemic lupus erythematosus.The Duality of Economic Issues With Medication Non-adherence in Patients With Inflammatory Arthritis.Compliance with treatment of rheumatoid arthritis.Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
P2860
Q26768683-71348436-7259-41CD-A513-3B937D68414EQ34566403-D7EF9586-CFBF-487F-9013-1F58ED1A7AC1Q35842618-32170593-D043-49DA-9B74-B2399573F712Q36171389-2125EED6-AC94-41C1-9A29-DB443EA53706Q36343561-55DEC0F4-656D-4C4A-AA52-7C1D99C56BEDQ36480601-AB680CAB-33AF-4C68-888F-3F76F8FBA032Q36733468-A605CCCB-77D9-4C60-A63A-35F2B69D7896Q36784125-D9858ED5-B524-424C-AA33-3361506B062DQ36931621-6C0C3CED-C40D-4D44-9DD4-9BCA10CA22F5Q36943002-4954AC85-A5F8-48E5-8486-F91A4EAEBFB1Q36950780-2DC82B4A-6D4C-4F7D-B338-7F68AF2B4DC8Q37196980-A7ECF5E1-39A2-4C5A-9E42-D882308D3362Q37337186-58A1F874-672E-4479-9750-309AC5F8FDDCQ37883966-E8765CC1-4413-4444-A27C-09CB6D8CC3E4Q38250160-734BC195-9DEA-4628-BBCA-1B2E0F101A3AQ38350358-E34B6E48-5B08-4DCA-96BA-7F7DB2C8D8ECQ38605850-587B5D2C-97E8-4461-9D24-41332D0A6D12Q38662236-655BEC8E-9BFA-44A8-B7C3-363E5705746CQ38819475-DE6D8B96-1402-4BF7-8909-DAE438FBFDB9Q45877225-1125AEA4-1A24-4FA3-A408-7D563F5B88A5Q46073827-9FA8DE02-0DF0-45E7-B3C0-FBB39599C087Q47102324-DD53BC32-001B-4E81-8774-3DD1E4BE7340Q47441501-14777BD2-E02E-4FFB-81AA-196B375AFD49Q47943997-E1D8AD06-9A34-4D40-81E7-015A3DDD1DF6Q50608134-C59BEF67-7763-435D-9B4D-E97511129A6EQ53369582-3E916185-2BA6-427F-9C01-413B63333620
P2860
Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment adherence to disease ...... systemic lupus erythematosus.
@ast
Treatment adherence to disease ...... systemic lupus erythematosus.
@en
Treatment adherence to disease ...... systemic lupus erythematosus.
@nl
type
label
Treatment adherence to disease ...... systemic lupus erythematosus.
@ast
Treatment adherence to disease ...... systemic lupus erythematosus.
@en
Treatment adherence to disease ...... systemic lupus erythematosus.
@nl
prefLabel
Treatment adherence to disease ...... systemic lupus erythematosus.
@ast
Treatment adherence to disease ...... systemic lupus erythematosus.
@en
Treatment adherence to disease ...... systemic lupus erythematosus.
@nl
P2860
P356
P1476
Treatment adherence to disease ...... systemic lupus erythematosus.
@en
P2093
Maria E Suarez-Almazor
Sofia de Achaval
P2860
P304
P356
10.2217/IJR.10.15
P577
2010-06-01T00:00:00Z